Tag: Pivotal

The Legal AI Software Companies Quadrant delivers an in-depth analysis of the global Legal AI Software market, spotlighting the top 23 leaders among 100 evaluated companies. This quadrant details key players, technological advancements, and market trends. Leveraging AI, ML, and NLP, legal AI software optimizes tasks like contract drafting, compliance management, and document review. Generative AI tools streamline operations, enhancing accuracy and competitiveness for law firms and corporate legal departments. Major players include LexisNexis, Thomson Reuters, and Wolters Kluwer, all pivotal in driving industry innovation and efficiency.

BEIJING, Aug. 05, 2025 (GLOBE NEWSWIRE) -- The "Symposium on International Cooperation for Digital Product Passport (DPP) and International Standards for Entire Lifecycle Management," organized by Zhongguancun Industry & Information Research Institute of Two-Dimensional Code Technology (ZIIOT), International Identification Code Industry Alliance (ICA), and the IEC 63538 Working Group, concluded successfully in Beijing. It unveiled the groundbreaking MA-DPP Universal Framework V1.0, an open international public good, providing standardized solutions for global supply chain digital transformation while seeking worldwide partners for joint implementation to facilitate smooth and stable global supply chains.

Wuppertal, Germany, August 5, 2025 - Aicuris Anti-infective Cures AG today announced initial clinical data from its ongoing first-in-human Phase 1 trial with AIC468. The novel antiviral antisense oligonucleotide is in development for the treatment of BK virus (BKV) infections in kidney transplant recipients. The interim results, presented at the World Transplant Congress in San Francisco on August 4, 2025, provide an overview of PK characteristics of AIC468 from the Phase 1 clinical trial in healthy volunteers.

Milan, Italy – August 5, 2025 – Tensive S.r.l, a clinical-stage advanced biomaterials medical device company, and the developer of REGENERA™ and SOFTAG™ bioresorbable scaffolds for breast reconstruction and tissue marking, has appointed Bill Hunter, MD, as Chairman of its Board of Directors. Dr. Hunter brings more than 30 years of leadership in the medical technology and life sciences sectors. His appointment reflects Tensive’s focus on strengthening its governance and expanding its global network as it accelerates toward pivotal clinical milestones and commercialization in the U.S. and Europe.